Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
.
. .
.
Chrome 2001
Chrome 2001
Health News Health News
.
Fertility Drugs May Not Raise Breast Cancer Risk: Study
April 03, 2014

 

THURSDAY, April 3, 2014 (HealthDay News) -- Widely used fertility drugs don't seem to increase a woman's risk of breast cancer, according to a new study.

Researchers analyzed data from more than 9,800 American women who were evaluated for infertility between 1965 and 1988 and followed until 2010. During the follow-up period, 749 of the women developed breast cancer.

Overall, women who took Clomid (clomiphene citrate) or gonadotropins as part of fertility treatments were not more likely to develop breast cancer than those who didn't take the drugs, according to the study in the current issue of the journal Cancer Epidemiology, Biomarkers and Prevention.

"We wanted to evaluate the long-term relationship of fertility medications and breast cancer risk after controlling for other factors that have been shown to be correlated with both breast cancer risk and use of those drugs," Louise Brinton, chief of the Hormonal and Reproductive Epidemiology Branch at the U.S. National Cancer Institute, said in a journal news release.

"Overall, our data show that use of fertility drugs does not increase breast cancer risk in this population of women, which is reassuring," she said.

The study did find that women who underwent 12 or more cycles of Clomid were about 1.5 times more likely to develop invasive breast cancer than those who never took fertility drugs.

It also found that women who didn't become pregnant after taking the fertility drugs were nearly twice as likely to develop invasive breast cancer as those who didn't take the two drugs.

"The observed increase in risk for these small subsets of women may be related to persistent infertility rather than an effect of the medications," Brinton noted. "Nevertheless, these findings stress the importance of continued monitoring of women who are exposed to fertility drugs."

She noted that the use of Clomid is typically limited to three to six cycles at doses up to 100 milligrams (mg), which is far lower than it was in the past. Some of the patients in this study were prescribed doses up to 250 mg, and many of them took that higher dose for many years.

"Given the high doses of drugs received by our study participants and the lack of large increases in breast cancer risk many years after exposure, women previously exposed to such drugs should be reassured by these findings," Brinton said.

"However, the women in our study who developed breast cancer were on average only 53 years old, which is still young in terms of when we usually expect breast cancers to develop," she added.

More information

The American Cancer Society outlines breast cancer risk factors.
Copyright © 2014 HealthDay. All rights reserved.


SOURCE: Cancer Epidemiology, Biomarkers & Prevention, news release, April 3, 2014...

InteliHealth
.
.
.
.
.
More News
InteliHealth .
.
General Health News
Today's News
Today In Health History
This Week In Health
Addiction News
Allergy News
Alzheimer's News
Arthritis News
Asthma News
Babies News
Breast Cancer News
Bronchitis News
Cancer News
Cervical Cancer News
Children's Health News
Cholesterol News
Dental/Oral Health News
Depression News
Diabetes News
Ear, Nose And Throat News
Environmental Health News
Eye News
Fitness News
Genetics News
Headache News
Health Policy News
Heart Attack News
Heart Failure News
Heart Health News
HIV/AIDS News
Infectious Diseases News
Influenza News
Lung Cancer News
Medication News
Men's Health News
Mental Health News
Multiple Sclerosis News
Nutrition News
Parkinson's News
Pregnancy News
Prostate Cancer News
Schizophrenia
Senior Health News
Sexual/Reproductive Health News
Sexual dysfunction
Sleep News
STDs News
Stroke News
Tobacco Cessation News
Weight Management News
Women's Health News
.
.
.
.
InteliHealth
    Print Printer-friendly format    
   
.  
This website is certified by Health On the Net Foundation. Click to verify.
.